About Envision Healthcare (NYSE:EVHC)
Envision Healthcare Holdings, Inc., formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc. (EmCare) and American Medical Response, Inc. (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States. Its AMR segment has developed a network of ambulance services and other healthcare transportation services in the United States. It provides Emergency Department (ED) physician services to hospitals and other facilities. Its hospitalist services include inpatient physician services. It provides anesthesiology services to hospitals, free-standing ambulatory surgery centers and physician offices. It provides radiology, including tele-radiology services to hospitals. It offers management, oversight and surgeon staffing for trauma surgery services.
Industry, Sector and Symbol
Industry Long-Term Care Facilities
Trailing P/E Ratio10.76
Forward P/E Ratio14.39
Sales & Book Value
Annual Sales$4.59 billion
Price / Sales0.94
Cash Flow$2.23 per share
Price / Cash16.06
Book Value$39.44 per share
Price / Book0.91
Return on Equity4.88%
Return on Assets2.02%
Envision Healthcare (NYSE:EVHC) Frequently Asked Questions
What is Envision Healthcare's stock symbol?
Envision Healthcare trades on the New York Stock Exchange (NYSE) under the ticker symbol "EVHC."
How will Envision Healthcare's stock buyback program work?
Envision Healthcare declared that its Board of Directors has approved a share buyback program on Tuesday, September 19th 2017, which authorizes the company to buyback $250,000,000.00 in shares, according to EventVestor. This buyback authorization authorizes the company to repurchase up to 4.5% of its stock through open market purchases. Stock buyback programs are generally an indication that the company's board of directors believes its shares are undervalued.
How were Envision Healthcare's earnings last quarter?
Envision Healthcare Co. (NYSE:EVHC) released its earnings results on Tuesday, October, 31st. The company reported $0.73 earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of $0.81 by $0.08. The company had revenue of $1.99 billion for the quarter, compared to the consensus estimate of $2.03 billion. Envision Healthcare had a negative net margin of 6.39% and a positive return on equity of 4.88%. The firm's revenue was up 142.0% compared to the same quarter last year. During the same period last year, the business earned $1.13 earnings per share. View Envision Healthcare's Earnings History.
When will Envision Healthcare make its next earnings announcement?
What guidance has Envision Healthcare issued on next quarter's earnings?
Envision Healthcare updated its fourth quarter earnings guidance on Tuesday, October, 31st. The company provided earnings per share guidance of $0.44-$0.54 for the period, compared to the Thomson Reuters consensus estimate of $1.01. The company issued revenue guidance of $1.88-$2.02 billion, compared to the consensus revenue estimate of $2.11 billion.
Where is Envision Healthcare's stock going? Where will Envision Healthcare's stock price be in 2018?
15 brokerages have issued 12 month price objectives for Envision Healthcare's shares. Their predictions range from $31.00 to $77.00. On average, they expect Envision Healthcare's share price to reach $38.64 in the next twelve months. View Analyst Ratings for Envision Healthcare.
What are Wall Street analysts saying about Envision Healthcare stock?
Here are some recent quotes from research analysts about Envision Healthcare stock:
- 1. Cantor Fitzgerald analysts commented, "Increasing 2018 estimates and updating PT. We are increasing our 2018 adjusted EPS estimate to $3.95 from $3.40 to reflect a lower corporate tax rate that adds $0.57 to adjusted EPS, offset by changes in the timing and estimated net proceeds from the AMR divestiture, which is now expected to close in 1Q18. Our adjusted 2018 EBITDA estimate remains $982 million, but our new price target reflects higher free cash flow from the lower taxes, and incremental margin improvements from reduced overhead labor costs." (1/5/2018)
- 2. According to Zacks Investment Research, "Envision Healthcare's stock has outperformed the industry in last one month. The company has taken some discrete actions which are expected to improve its operating performance and realize $50 million of incremental adjusted EBITDA in 2018. It is optimistic about the physician services market, which is witnessing consolidation. Also the divestiture of its AMR business will help the company to focus on its core operations. The company is aggressively shifting its payor contract to in-network from out of network which will lead to greater client and patient satisfaction, competitive differentiation, administrative efficiency, enhanced collections and an accelerated cash flow. But, it suffers from high indebtedness, consequently leading to an increase in the interest ratio. Also, its operating expense is on the rise and is exceeding the revenue growth to have exerted pressure on the operating margins." (1/2/2018)
- 3. Jefferies Group LLC analysts commented, "Investors have been anticipating a volume-driven FY17 guidance miss for the last few months, as evidenced by the discount in its valuation, so last night's guidance shortfall, while wider than expectations, does not come as a surprise. We remain Buy-rated given our view that EVHC's fundamentals are intact; guidance is reasonable/conservative; valuation is compelling, and AMR sale could drive incremental share upside." (3/1/2017)
Who are some of Envision Healthcare's key competitors?
Some companies that are related to Envision Healthcare include Exelixis (EXEL), Juno Therapeutics (JUNO), Bio-Rad Laboratories (BIO), West Pharmaceutical Services (WST), Bioverativ (BIVV), Stada Arzneimittel (STDAF), Ionis Pharmaceuticals (IONS), Icon (ICLR), EXACT Sciences (EXAS), Hill-Rom (HRC), Catalent (CTLT), Galapagos (GLPG), Olympus (OCPNY), Hutchison China MediTech (HCM), BIO-TECHNE (TECH), Beigene (BGNE), Orion (ORINY) and Patheon (PTHN).
Who owns Envision Healthcare stock?
Envision Healthcare's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Hexavest Inc. (0.54%), Schwab Charles Investment Management Inc. (0.54%), Factory Mutual Insurance Co. (0.35%), Bank of Montreal Can (0.03%), Sit Investment Associates Inc. (0.03%) and State of Alaska Department of Revenue (0.02%). Company insiders that own Envision Healthcare stock include John Thomas Gawaluck and Robert Jon Coward. View Institutional Ownership Trends for Envision Healthcare.
Who sold Envision Healthcare stock? Who is selling Envision Healthcare stock?
Envision Healthcare's stock was sold by a variety of institutional investors in the last quarter, including Schwab Charles Investment Management Inc., Exxonmobil Investment Management Inc. TX and Sit Investment Associates Inc.. View Insider Buying and Selling for Envision Healthcare.
Who bought Envision Healthcare stock? Who is buying Envision Healthcare stock?
Envision Healthcare's stock was bought by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue, Factory Mutual Insurance Co., Fox Run Management L.L.C., Atria Investments LLC, Hexavest Inc. and Bank of Montreal Can. View Insider Buying and Selling for Envision Healthcare.
How do I buy Envision Healthcare stock?
Shares of Envision Healthcare can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Envision Healthcare's stock price today?
One share of Envision Healthcare stock can currently be purchased for approximately $35.83.
How big of a company is Envision Healthcare?
Envision Healthcare has a market capitalization of $4.21 billion and generates $4.59 billion in revenue each year. The company earns $-18,600,000.00 in net income (profit) each year or ($5.00) on an earnings per share basis. Envision Healthcare employs 65,200 workers across the globe.
How can I contact Envision Healthcare?
Envision Healthcare's mailing address is 1A BURTON HILLS BOULEVARD, NASHVILLE TN, 37215. The company can be reached via phone at 615-665-1283 or via email at [email protected]
MarketBeat Community Rating for Envision Healthcare (EVHC)MarketBeat's community ratings are surveys of what our community members think about Envision Healthcare and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Envision Healthcare (NYSE:EVHC) Analysts' Consensus Rating (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus analyst ratings for company stocks using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Today||30 Days Ago||90 Days Ago||180 Days Ago|
|Consensus Rating: ||Buy||Buy||Buy||Buy|
|Consensus Rating Score: ||2.60||2.69||3.00||3.00|
|Ratings Breakdown: ||0 Sell Rating(s)|
6 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
|0 Sell Rating(s)|
6 Hold Rating(s)
9 Buy Rating(s)
1 Strong Buy Rating(s)
|0 Sell Rating(s)|
1 Hold Rating(s)
11 Buy Rating(s)
1 Strong Buy Rating(s)
|0 Sell Rating(s)|
1 Hold Rating(s)
9 Buy Rating(s)
1 Strong Buy Rating(s)
|Consensus Price Target: ||$38.64||$41.47||$73.30||$72.13|
|Price Target Upside: ||10.66% upside||20.12% upside||76.84% upside||15.20% upside|
Envision Healthcare (NYSE:EVHC) Consensus Price Target History
Envision Healthcare (NYSE:EVHC) Analyst Ratings History
(Data available from 1/20/2016 forward)
Envision Healthcare (NYSE:EVHC) Earnings History and Estimates Chart
Envision Healthcare (NYSE EVHC) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|2/27/2018|| || || || || || || || |
|10/31/2017||Q3 2017||$0.81||$0.73||$2.03 billion||$1.99 billion||View||N/A|
|8/7/2017||Q2 2017||$0.75||$0.79||$1.96 billion||$1.95 billion||View||Listen|
|5/2/2017||Q1 2017||$0.69||$0.69||$2.52 billion||$1.88 billion||View||Listen|
|2/28/2017||Q416||$1.20||$1.08||$1.41 billion||$1.39 billion||View||Listen|
|11/1/2016||Q316||$0.36||$0.36||$1.67 billion||$1.64 billion||View||N/A|
|8/2/2016||Q216||$0.36||$0.34||$1.66 billion||$1.64 billion||View||N/A|
|5/3/2016||Q1||$0.25||$0.28||$1.55 billion||$1.60 billion||View||N/A|
|2/24/2016||Q415||$0.35||$0.35||$1.45 billion||$1.48 billion||View||Listen|
|10/22/2015||Q315||$0.39||$0.30||$1.41 billion||$1.37 billion||View||Listen|
|8/4/2015||Q215||$0.35||$0.37||$1.30 billion||$1.35 billion||View||Listen|
|5/5/2015||Q115||$0.26||$0.26||$1.19 billion||$1.24 billion||View||N/A|
|2/25/2015||Q414||$0.36||$0.36||$1.16 billion||$1.16 billion||View||N/A|
|11/4/2014||Q314||$0.33||$0.35||$1.13 billion||$1.15 billion||View||N/A|
|7/31/2014||Q214||$0.25||$0.28||$1.04 billion||$1.08 billion||View||N/A|
|4/22/2014||Q114||$0.19||$0.20||$1.02 billion||$1.01 billion||View||N/A|
|3/5/2014||Q413||$0.17||$0.20||$994.41 million||$984.80 million||View||N/A|
|11/13/2013||Q3 13||$0.13||$0.13||$950.22 million||$955.90 million||View||N/A|
Envision Healthcare (NYSE:EVHC) Earnings Estimates
2018 EPS Consensus Estimate: $2.68
(Earnings estimates data provided by Zacks Investment Research)
|Quarter||Number of Estimates||Low Estimate||High Estimate||Average Estimate|
Dividend History for Envision Healthcare (NYSE:EVHC)
No dividend announcements for this company have been tracked by MarketBeat.com
Envision Healthcare (NYSE EVHC) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 3.10%
Envision Healthcare (NYSE EVHC) Insider Trades by Quarter
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|7/3/2017||Robert Jon Coward||Insider||Sell||1,500||$62.69||$94,035.00||97,863|| |
|6/22/2017||Robert Jon Coward||Insider||Sell||1,500||$60.00||$90,000.00||99,363|| |
|5/3/2017||Robert Jon Coward||Insider||Sell||1,500||$60.53||$90,795.00||114,363|| |
|4/3/2017||Robert Jon Coward||Insider||Sell||1,500||$61.34||$92,010.00||115,863|| |
|3/10/2017||John Thomas Gawaluck||Director||Buy||1,500||$66.65||$99,975.00||6,080|| |
|3/1/2017||Robert Jon Coward||Insider||Sell||1,500||$65.00||$97,500.00||104,319|| |
|10/5/2015||Leonard M Riggs Jr||Director||Sell||4,000||$36.24||$144,960.00||32,179|| |
|9/15/2015||Randel G Owen||CFO||Sell||20,000||$42.00||$840,000.00||367,683|| |
|9/14/2015||William A. Sanger||CEO||Sell||175,000||$41.06||$7,185,500.00|| |
|8/17/2015||Randel G Owen||CFO||Sell||140,000||$44.22||$6,190,800.00|| |
|8/17/2015||Todd G Zimmerman||CEO||Sell||180,000||$44.21||$7,957,800.00|| |
|7/6/2015||Leonard M Riggs Jr||Director||Sell||4,000||$39.32||$157,280.00|| |
|6/25/2015||Dighton Packard||Insider||Sell||40,000||$40.00||$1,600,000.00|| |
|4/20/2015||Dighton Packard||Insider||Sell||240,188||$39.44||$9,473,014.72|| |
|4/16/2015||Horne Edward Van||Insider||Sell||10,000||$40.00||$400,000.00|| |
|4/16/2015||William A Sanger||CEO||Sell||418,500||$40.00||$16,740,000.00|| |
|4/13/2015||Craig A Wilson||SVP||Sell||18,600||$39.57||$736,002.00|| |
|4/13/2015||Leonard M Riggs Jr||Director||Sell||4,000||$39.57||$158,280.00|| |
|3/19/2015||Horne Edward Van||Insider||Sell||12,000||$38.00||$456,000.00|| |
|3/19/2015||Randel G Owen||CFO||Sell||50,000||$38.04||$1,902,000.00|| |
|3/16/2015||Richard J Schnall||Director||Buy||100,000||$36.73||$3,673,000.00|| |
|3/9/2015||Steven G Murphy||SVP||Sell||12,021||$36.03||$433,116.63|| |
|2/25/2015||William A Sanger||CEO||Sell||153,782||$37.50||$5,766,825.00|| |
|2/23/2015||William A Sanger||CEO||Sell||7,100||$37.54||$266,534.00|| |
|1/9/2015||William A Sanger||CEO||Sell||194,968||$37.52||$7,315,199.36|| |
|1/8/2015||Randel G Owen||CFO||Sell||200,000||$36.56||$7,312,000.00|| |
|10/31/2014||Randel G Owen||CFO||Sell||19,180||$35.00||$671,300.00|| |
|10/28/2014||Randel G Owen||CFO||Sell||30,820||$35.00||$1,078,700.00|| |
|10/24/2014||Todd G Zimmerman||CEO||Sell||125,000||$35.00||$4,375,000.00|| |
|10/22/2014||Horne Edward Van||Insider||Sell||6,540||$35.00||$228,900.00|| |
|10/6/2014||Horne Edward Van||Insider||Sell||10,200||$35.00||$357,000.00|| |
|10/1/2014||Horne Edward Van||Insider||Sell||10,606||$34.67||$367,710.02|| |
|9/29/2014||Dighton Packard||Insider||Sell||32,400||$34.97||$1,133,028.00|| |
|9/29/2014||Michael L Smith||Director||Sell||7,000||$34.97||$244,790.00|| |
|9/29/2014||Randel G Owen||CFO||Sell||150,000||$34.97||$5,245,500.00|| |
|9/29/2014||Steve W Ratton Jr||EVP||Sell||25,000||$34.97||$874,250.00|| |
|9/29/2014||William A Sanger||CEO||Sell||200,000||$34.97||$6,994,000.00|| |
|9/15/2014||Steven G Murphy||SVP||Sell||45,988||$34.75||$1,598,083.00|| |
|7/16/2014||Horne Edward Van||Insider||Sell||20,269||$32.90||$666,850.10|| |
|7/16/2014||Leonard M Riggs Jr||Director||Sell||15,000||$32.90||$493,500.00|| |
|7/16/2014||Randel G Owen||CFO||Sell||249,375||$32.90||$8,204,437.50|| |
|7/16/2014||Steve W Ratton Jr||EVP||Sell||42,948||$32.90||$1,412,989.20|| |
|7/16/2014||Steven G Murphy||SVP||Sell||21,852||$32.90||$718,930.80|| |
|7/16/2014||William A Sanger||CEO||Sell||543,900||$32.90||$17,894,310.00|| |
|8/19/2013||Leonard M Riggs Jr||Director||Buy||44,000||$23.00||$1,012,000.00|| |
|8/19/2013||Steven G Murphy||SVP||Buy||5,000||$23.00||$115,000.00|| |
Envision Healthcare (NYSE EVHC) News Headlines
|Envision Healthcare Co. (EVHC) Receives Average Rating of "Hold" from Analysts|
www.americanbankingnews.com - January 19 at 4:34 AM
|Q1 2018 EPS Estimates for Envision Healthcare Co. (EVHC) Raised by Analyst|
www.americanbankingnews.com - January 18 at 10:28 AM
|Q2 2018 EPS Estimates for Envision Healthcare Co. (EVHC) Reduced by Analyst|
www.americanbankingnews.com - January 17 at 2:40 PM
|Envision Healthcare (EVHC) Stock Rating Reaffirmed by Stephens|
www.americanbankingnews.com - January 10 at 9:12 AM
|Envision Healthcare Co. (EVHC) Expected to Announce Quarterly Sales of $1.98 Billion|
www.americanbankingnews.com - January 10 at 2:42 AM
|Haeggquist & Eck Investigates Breach of Fiduciary Duties by Envision Healthcare Officers and Directors Regarding Improper “Surprise” Emergency Room Billing|
finance.yahoo.com - January 9 at 9:32 AM
|Envision Healthcare Co. (EVHC) Expected to Post Earnings of $0.49 Per Share|
www.americanbankingnews.com - January 8 at 9:38 PM
|Will Envision Healthcare's Growth Strategies Help the Stock?|
www.zacks.com - January 5 at 5:05 PM
|Envision Healthcare (EVHC) Earns "Hold" Rating from Cantor Fitzgerald|
www.americanbankingnews.com - January 5 at 1:34 PM
|Envision Healthcare (EVHC) Affirms Q4 Guidance, Provides Business & Governance Update - StreetInsider.com|
www.streetinsider.com - January 4 at 5:18 PM
|Envision Healthcare Provides Business & Governance Update|
finance.yahoo.com - January 4 at 5:18 PM
|4 Reasons Why Envision Healthcare Is Looking Dull|
www.benzinga.com - December 28 at 1:37 PM
|The Hot Stock: Envision Healthcare Climbs 2.4%|
finance.yahoo.com - December 28 at 1:37 PM
|Envision Healthcare Was the S&P 500’s Top Gainer on December 27|
finance.yahoo.com - December 28 at 1:37 PM
|Envision Healthcare Co. (EVHC) Receives Average Recommendation of "Buy" from Analysts|
www.americanbankingnews.com - December 25 at 3:57 AM
|$0.49 EPS Expected for Envision Healthcare Co. (EVHC) This Quarter|
www.americanbankingnews.com - December 23 at 1:10 PM
|Envision Healthcare: S&P 500’s Top Gainer on December 21|
finance.yahoo.com - December 22 at 9:39 AM
|Envision Healthcare (EVHC) Given a $40.00 Price Target by SunTrust Banks Analysts|
www.americanbankingnews.com - December 22 at 7:16 AM
|Jefferies Group Analysts Lower Earnings Estimates for Envision Healthcare Co. (EVHC)|
www.americanbankingnews.com - December 22 at 6:52 AM
|Nashville health care company strikes $31 million settlement with DOJ - Nashville Business Journal|
www.bizjournals.com - December 21 at 5:18 PM
|Envision Healthcare Co. (EVHC) Expected to Post Q1 2018 Earnings of $0.47 Per Share|
www.americanbankingnews.com - December 21 at 1:32 PM
|Nashville health care company strikes $31 million settlement with DOJ|
finance.yahoo.com - December 20 at 5:17 PM
|Envision Healthcare (EVHC) to Pay $31M in DOJ Settlement - StreetInsider.com|
www.streetinsider.com - December 19 at 5:19 PM
|Envision Healthcare Corp. – Value Analysis (NYSE:EVHC) : December 19, 2017|
finance.yahoo.com - December 19 at 5:19 PM
|Envision Healthcare (EVHC) PT Set at $41.00 by Jefferies Group|
www.americanbankingnews.com - December 19 at 9:46 AM
|ETFs with exposure to Envision Healthcare Corp. : December 18, 2017|
finance.yahoo.com - December 18 at 5:19 PM
|Update in Lawsuit for Investors in (NYSE: EVHC) shares against Envision Healthcare Corp announced by Shareholders Foundation|
finance.yahoo.com - December 18 at 9:50 AM
|Envision Healthcare Target of Unusually High Options Trading (EVHC)|
www.americanbankingnews.com - December 15 at 2:38 AM
|Envision Healthcare (EVHC) Coverage Initiated by Analysts at Piper Jaffray Companies|
www.americanbankingnews.com - December 13 at 11:10 PM
|Piper Jaffray Starts Envision Healthcare (EVHC) at Neutral - StreetInsider.com|
www.streetinsider.com - December 13 at 5:28 PM
|Envision Healthcare (EVHC) Receives New Coverage from Analysts at Credit Suisse Group|
www.americanbankingnews.com - December 11 at 7:52 PM
|ETFs with exposure to Envision Healthcare Corp. : December 7, 2017|
finance.yahoo.com - December 7 at 5:44 PM
|Zacks: Analysts Expect Envision Healthcare Co. (EVHC) Will Post Quarterly Sales of $1.98 Billion|
www.americanbankingnews.com - December 7 at 12:18 PM
|$0.57 EPS Expected for Envision Healthcare Co. (EVHC) This Quarter|
www.americanbankingnews.com - December 5 at 7:26 PM
|Envision Healthcare Co. (EVHC) Given Consensus Rating of "Buy" by Analysts|
www.americanbankingnews.com - November 30 at 3:40 AM
|ETFs with exposure to Envision Healthcare Corp. : November 27, 2017|
finance.yahoo.com - November 27 at 5:53 PM
|Implied Volatility Surging for Envision Healthcare (EVHC) Stock Options - Nasdaq|
www.nasdaq.com - November 22 at 7:09 PM
|Implied Volatility Surging for Envision Healthcare (EVHC) Stock Options|
finance.yahoo.com - November 21 at 6:39 PM
|Robert W. Baird Analysts Give Envision Healthcare Corporation (EVHC) a $35.00 Price Target|
www.americanbankingnews.com - November 19 at 10:20 PM
|Envision Healthcare Corporation (EVHC) Expected to Announce Quarterly Sales of $1.98 Billion|
www.americanbankingnews.com - November 19 at 2:54 PM
|Envision Healthcare Corporation (EVHC) PT Set at $31.00 by Mizuho|
www.americanbankingnews.com - November 18 at 2:18 PM
|Robbins Arroyo LLP Is Investigating the Officers and Directors of Envision Healthcare Corporation (EVHC) on Behalf ... - Business Wire (press release)|
www.businesswire.com - November 14 at 11:53 PM
|Envision Healthcare Corporation's (EVHC) "Hold" Rating Reaffirmed at Cantor Fitzgerald|
www.americanbankingnews.com - November 14 at 11:03 PM
|ETFs with exposure to Envision Healthcare Corp. : November 14, 2017|
finance.yahoo.com - November 14 at 6:53 PM
|Envision Healthcare Corporation (EVHC) Given a $40.00 Price Target at KeyCorp|
www.americanbankingnews.com - November 14 at 3:18 PM
|Robbins Arroyo LLP Is Investigating the Officers and Directors of Envision Healthcare Corporation (EVHC) on Behalf of Shareholders|
finance.yahoo.com - November 13 at 6:58 PM
|Envision Healthcare Corp. :EVHC-US: Earnings Analysis: Q3, 2017 By the Numbers : November 13, 2017|
finance.yahoo.com - November 13 at 10:21 AM
|Envision Healthcare Hits 52-Week Low on Q3 Miss, Grim View (Revised) - Nasdaq|
www.nasdaq.com - November 8 at 6:42 AM
|Envision Healthcare Hits 52-Week Low on Q3 Miss, Grim View (Revised)|
finance.yahoo.com - November 8 at 6:42 AM
|Why Envision Healthcare Is Spiraling Downward|
finance.yahoo.com - November 6 at 8:04 PM
Envision Healthcare (NYSE:EVHC) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Envision Healthcare (NYSE:EVHC) Income Statement, Balance Sheet and Cash Flow Statement
Envision Healthcare (NYSE EVHC) Stock Chart for Saturday, January, 20, 2018